Literature DB >> 3026962

MHC class II antigen and immunoglobulin expression in spontaneous phenotypic variants of the Burkitt's lymphoma cell line Namalwa.

K Guy, P G Middleton, L J Docherty, C L De Angelis, C M Steel.   

Abstract

Phenotypic variant sublines of the Burkitt's lymphoma cell line Namalwa were examined with cDNA probes for the different MHC class II beta chain genes and with monoclonal antibodies specific for the corresponding cell surface antigens (DP, DQ and DR antigens). Expression of MHC class II antigens in the Namalwa sublines (known as CSN/70, IPN/45, PNT and KN2) was compared with that of the B-lymphoblastoid cell line DEW1, which is identical to Namalwa in DR allotype (DR 2,4). There were markedly different levels of expression of MHC class II antigens among the cell lines: in DEW1 and the Namalwa KN2 subline DP, DQ and DR antigens were expressed on almost all the cells. On the PNT and IPN/45 sublines, DR antigens were expressed on all the cells, and DP and DQ antigens were expressed at detectable levels on only a proportion of cells. On CSN/70, there was weak expression of DR antigens on a minority of cells and no detectable expression of DP and DQ antigens. When examined with MHC class II-specific cDNAs, restriction fragment patterns of DNA were identical for all the cell lines, suggesting that they had structurally identical MHC class II genes. In the Namalwa cell lines the synthesis of Ig and the expression of MHC class II antigens were coordinately regulated.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3026962      PMCID: PMC1453332     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  47 in total

1.  The modulation of membrane Ia on human B lymphocytes.

Authors:  J H Kehrl; A Muraguchi; A S Fauci
Journal:  Cell Immunol       Date:  1985-05       Impact factor: 4.868

2.  An HLA class I specific monoclonal antibody that fails to bind to all HLA-A antigens.

Authors:  S A Ellis; C Taylor; J E Hildreth; A J McMichael
Journal:  Hum Immunol       Date:  1985-05       Impact factor: 2.850

3.  Immunohistochemical analysis of human MHC class II antigens in B-cell non-Hodgkin's lymphomas.

Authors:  A S Krajewski; K Guy; A E Dewar; D Cossar
Journal:  J Pathol       Date:  1985-02       Impact factor: 7.996

4.  Unique allelic restriction fragments of the human Ha-ras locus in leukocyte and tumour DNAs of cancer patients.

Authors:  T G Krontiris; N A DiMartino; M Colb; D R Parkinson
Journal:  Nature       Date:  1985 Jan 31-Feb 6       Impact factor: 49.962

5.  Antibodies to surface IgM and IgD increase the expression of various class II antigens on human B cells.

Authors:  T Godal; C Davies; E B Smeland; R Heikkilä; S Funderud; H B Steen; K Hildrum
Journal:  Eur J Immunol       Date:  1985-02       Impact factor: 5.532

6.  Reactivation by a trans-acting factor of human major histocompatibility complex Ia gene expression in interspecies hybrids between an Ia-negative human B-cell variant and an Ia-positive mouse B-cell lymphoma.

Authors:  R S Accolla; G Carra; J Guardiola
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

7.  Divergent expression of HLA-DC/MB, -DR, and -SB region products on normal and pathological tissues as detected by monoclonal antibodies.

Authors:  C Müller; A Ziegler; C Muller; M Hadam; H D Waller; P Wernet; G Müller
Journal:  Immunobiology       Date:  1985-04       Impact factor: 3.144

8.  Cellular distribution of a human I-A-like (DS/DC) antigen on normal and neoplastic lymphoid cells.

Authors:  G E Marti; L M Nadler; T M Chused; G Tosato; R M Blaese; T J Kindt
Journal:  Hum Immunol       Date:  1985-01       Impact factor: 2.850

9.  Specificity of monoclonal antibodies directed against human and murine class II histocompatibility antigens as analyzed by binding to HLA-deletion mutant cell lines.

Authors:  S Shaw; A Ziegler; R DeMars
Journal:  Hum Immunol       Date:  1985-04       Impact factor: 2.850

10.  The gross pathology and histological features of tumours produced by inoculation of human cell lines into immune-deprived mice.

Authors:  A Busuttil; G T O'Conor; M E Foster; V Gurtsevitch; J E Morten; C M Steel
Journal:  J Pathol       Date:  1986-04       Impact factor: 7.996

View more
  2 in total

1.  A Lentiviral Vector Allowing Physiologically Regulated Membrane-anchored and Secreted Antibody Expression Depending on B-cell Maturation Status.

Authors:  Floriane Fusil; Sara Calattini; Fouzia Amirache; Jimmy Mancip; Caroline Costa; Justin B Robbins; Florian Douam; Dimitri Lavillette; Mansun Law; Thierry Defrance; Els Verhoeyen; François-Loïc Cosset
Journal:  Mol Ther       Date:  2015-08-18       Impact factor: 11.454

2.  Variant sublines of the human B-lymphoma cells Namalwa are at different stages of differentiation.

Authors:  K Guy; P G Middleton; C M Steel
Journal:  Immunology       Date:  1987-07       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.